Comparison of apoptosis detection markers combined with macrophage immunostaining to study phagocytosis of apoptotic cells in situ.
Efficient phagocytosis of cells undergoing apoptosis by macrophages is important to prevent immunological responses and development of chronic inflammatory disorders such as systemic lupus erythematosus, cystic fibrosis and atherosclerosis. To study phagocytosis of apoptotic cells (AC) by macrophages in tissue, we validated different apoptosis markers (DNA fragmentation, caspase-3 activation and cleavage of its substrate poly(ADP-ribose)polymerase-1) in combination with macrophage immunostaining. Human tonsils were used as a model because they show a high apoptosis frequency under physiological conditions as well as efficient phagocytosis of AC by macrophages. On the other hand, advanced human atherosclerotic plaques were examined since plaques show severely impaired phagocytosis of AC. Our results demonstrate that the presence of non-phagocytized terminal deoxynucleotidyl transferase end labelling (TUNEL)-positive AC represents a suitable marker of poor phagocytosis by macrophages in situ. Other markers for apoptosis, such as cleavage of caspase-3 or PARP-1, should not be used to assess phagocytosis efficiency, because activation of the caspase cascade and cleavage of their substrates can occur in AC when they have not yet been phagocytized by macrophages.
Schrijvers
Dorien M
DM
Division of Pharmacology, University of Antwerp, Wilrijk, Belgium.
De Meyer
Guido R Y
GR
Kockx
Mark M
MM
Herman
Arnold G
AG
Martinet
Wim
W
Hepatology. 1995 May;21(5):1465-8
7737654
Am J Pathol. 1998 Apr;152(4):885-8
9546348
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1256-61
15831805
Cell Death Differ. 2003 Jan;10(1):108-16
12655299
FEBS Lett. 2000 Jan 7;465(1):47-52
10620704
J Clin Invest. 2001 Oct;108(7):957-62
11581295
Eur J Immunol. 1996 Jun;26(6):1211-6
8647194
Immunol Cell Biol. 2003 Aug;81(4):289-96
12848850
Arthritis Rheum. 2002 Jan;46(1):191-201
11817590
Arthritis Rheum. 2003 Oct;48(10):2888-97
14558095
J Clin Invest. 2002 Mar;109(5):661-70
11877474
Neurosci Lett. 1996 Aug 2;213(2):111-4
8858621
Neurosci Lett. 1997 Jul 11;230(1):1-4
9259449
Cancer Metastasis Rev. 1992 Sep;11(2):95-103
1394797
Ann Rheum Dis. 2004 Jul;63(7):774-84
15194571
Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8485-9
1924307
Cell. 2003 Jun 13;113(6):717-30
12809603
J Immunol Methods. 2004 Apr;287(1-2):101-8
15099759
Ann Rheum Dis. 2005 Feb;64(2):342-3; author reply 343-4
15647451
Arthritis Rheum. 2004 Jun;50(6):1873-83
15188364
Genes Dev. 1998 Mar 15;12(6):806-19
9512515
Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2524-34
10521383